Abstract
Aim: To analyze the cost of three bed bath technologies in critically ill cardiac patients. Study design: Non-participant, prospective, observational, and cost assessment study. Data were collected between February and August 2017, at the cardiac intensive care (ICU) of a university hospital. The convenience sample corresponded to 18 patients in the immediate postoperative period of cardiac surgery. Data were collected within 72 h after cardiac surgery, with 24-hour washout between baths. Project was approved under the number: 1.823.316. Results: The mean time for bed bath was 39.00±15.00 min (traditional bath), 33.00±12.24 min (distilled water bath) and 25.28±7.35 min (disposable bath). The average final costs identified were R$ 45.47 (US$ 8.80), R$ 40.78 (US$ 7.89) and R$ 48.36 (US$ 9.36). Conclusion: The bath with the lowest total average cost was the distilled water bath. The cost category that most burdens the bed baths is human capital, which represents more than 2/3 of the procedures total cost. There are few studies exploring the costs associated to nursing procedures, and this analysis can contribute to discussions about materials purchase and support managers to make better decisions about nursing care.
Highlights
The economic evaluation area in healthcare joins the economy rationalization to decision making in this sector (Zechmeister-Koss et al, 2019)
This study evaluates the bed bath, an exclusive nursing technique in health institutions and a procedure that, specially in Intensive Care Units (ICU), requires specialized and qualified professionals due to clinical instability of patients (Lima & Lacerda, 2010; Lôbo et al, 2020)
The aim of this study is to perform an economic evaluation of three bed bath technologies in patients hospitalized in ICU during the cardiac post-operative period
Summary
The economic evaluation area in healthcare joins the economy rationalization to decision making in this sector (Zechmeister-Koss et al, 2019). In Brazil and around the world, health systems and their managers are facing challenges to offer quality health care to the population considering the available resources (Brazil, 2009; Zechmeister-Koss et al, 2019) These challenges can be described as growing technological innovation, proportional arise of spending, restriction of budget resources, industry, media and population impositions and the process of health judicialization (Brazil, 2009; Freitas et al, 2020). Managers need trustworthy information about the benefits of a technology and its costs, mainly in the public health system This information should emerge from clinical evidence to subsidize effectively the decision making and direct formulation of public politics (Laranjeira et al, 2012). It is fundamental to implement a new research field: Health Technology Assessment (HTA) (Brazil, 2006)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
